Strata Critical Medical (NASDAQ:SRTA) CAO Amir Cohen Sells 4,655 Shares

Posted by Francis Steltz on Jun 10th, 2026

Strata Critical Medical (NASDAQ:SRTA – Get Free Report) CAO Amir Cohen sold 4,655 shares of the company’s stock in a transaction on Monday, June 8th. The stock was sold at an average price of $5.87, for a total transaction of $27,324.85. Following the completion of the transaction, the chief accounting officer owned 146,608 shares of the company’s stock, valued at $860,588.96. This trade represents a 3.08% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Amir Cohen also recently made the following trade(s):

On Friday, May 22nd, Amir Cohen sold 40,575 shares of Strata Critical Medical stock. The shares were sold at an average price of $5.91, for a total transaction of $239,798.25.
On Thursday, May 21st, Amir Cohen sold 10,300 shares of Strata Critical Medical stock. The shares were sold at an average price of $5.79, for a total transaction of $59,637.00.

Strata Critical Medical Stock Performance

NASDAQ SRTA traded down $0.13 during trading on Wednesday, hitting $5.48. 1,306,562 shares of the company’s stock traded hands, compared to its average volume of 874,584. The business’s fifty day moving average price is $5.14. Strata Critical Medical has a 12-month low of $3.57 and a 12-month high of $6.50. The firm has a market cap of $474.18 million, a price-to-earnings ratio of -68.50 and a beta of 2.20.

Strata Critical Medical (NASDAQ:SRTA – Get Free Report) last posted its quarterly earnings results on Wednesday, May 6th. The company reported $0.03 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.04) by $0.07. Strata Critical Medical had a net margin of 20.56% and a negative return on equity of 4.06%. The business had revenue of $67.38 million during the quarter. On average, sell-side analysts anticipate that Strata Critical Medical will post -0.14 earnings per share for the current year.

Hedge Funds Weigh In On Strata Critical Medical

Hedge funds and other institutional investors have recently modified their holdings of the company. Bank of America Corp DE raised its stake in shares of Strata Critical Medical by 16.2% during the first quarter. Bank of America Corp DE now owns 181,574 shares of the company’s stock valued at $759,000 after acquiring an additional 25,379 shares during the last quarter. Quantinno Capital Management LP lifted its holdings in Strata Critical Medical by 98.7% in the first quarter. Quantinno Capital Management LP now owns 143,239 shares of the company’s stock worth $599,000 after buying an additional 71,155 shares during the period. Dimensional Fund Advisors LP lifted its holdings in Strata Critical Medical by 11.9% in the first quarter. Dimensional Fund Advisors LP now owns 1,617,104 shares of the company’s stock worth $6,759,000 after buying an additional 172,154 shares during the period. Principal Financial Group Inc. purchased a new stake in Strata Critical Medical in the first quarter worth about $537,000. Finally, Seelaus Asset Management LLC lifted its holdings in Strata Critical Medical by 32.7% in the first quarter. Seelaus Asset Management LLC now owns 24,350 shares of the company’s stock worth $102,000 after buying an additional 6,000 shares during the period. 47.36% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

SRTA has been the subject of several analyst reports. B. Riley Financial initiated coverage on shares of Strata Critical Medical in a research report on Wednesday, March 25th. They set a “buy” rating and a $8.00 price target for the company. Craig Hallum began coverage on shares of Strata Critical Medical in a research report on Wednesday, March 25th. They set a “buy” rating and a $8.00 price target for the company. Zacks Research raised shares of Strata Critical Medical to a “hold” rating in a research note on Thursday, March 26th. Finally, Weiss Ratings raised shares of Strata Critical Medical from a “hold (c-)” rating to a “hold (c)” rating in a research note on Monday, May 11th. One investment analyst has rated the stock with a Strong Buy rating, one has given a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $8.00.

Check Out Our Latest Research Report on SRTA

Strata Critical Medical Company Profile

(Get Free Report)

Blade Air Mobility, Inc provides air transportation alternatives to the congested ground routes in the United States. It provides its services through charter and by-the-seat flights using helicopters, jets, turboprops, and amphibious seaplanes. The company was founded in 2014 and is headquartered in New York, New York.